title: [Role of NO/cGMP signaling cascade in the development of opium dependency].
abstract: This study was aimed at evaluating the role of nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) cascade in mechanisms of morphine dependency formation. Morphine was introduced by intraperitoneal (i.p.) injections in rats twice per day over six days in doses increasing from 10 to 100 mg/kg, For evaluating the role of NO/cGMP cascade, NO synthase inhibitor L-N(G)-Nitroarginine methyl ester (L-NAME) was introduced (10 mg/kg, i.p.) 1 h prior to every injection of morphine. The L-NAME introduction led to enhancement of spontaneous withdrawal syndrome manifestations, which was accompanied by more pronounced decrease in the cGMP levels in midbrain and striatum. It is suggested that the region specific decrease in NO/cGMP cascade signaling activity in the brain can be among mechanisms determining the development of opium dependency.
authors.forename: D I
authors.initials: DI
authors.lastname: Peregud
authors.forename: A A
authors.initials: AA
authors.lastname: Iakovleva
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Stepanichev
authors.forename: L F
authors.initials: LF
authors.lastname: Panchenko
authors.forename: N V
authors.initials: NV
authors.lastname: Guliaeva
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D008297:Male; D008636:Mesencephalon / Q000378:metabolism*; D009020:Morphine / Q000009:adverse effects / Q000494:pharmacology; D009021:Morphine Dependence / Q000378:metabolism*; D019331:NG-Nitroarginine Methyl Ester / Q000009:adverse effects / Q000494:pharmacology; D009294:Narcotics / Q000009:adverse effects / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013375:Substance Withdrawal Syndrome / Q000378:metabolism
chemical_list: D009294:Narcotics; D009569:Nitric Oxide; D009020:Morphine; D006152:Cyclic GMP; D019331:NG-Nitroarginine Methyl Ester